(2R,4R)-Monatin exists naturally in small quantities in the root bark of the South African plant, Sclerochitin ilicifolius.
Enzymatically-synthesized (2R,4R)-monatin has been evaluated for potential use as a food ingredient.
QT internal prolongation was observed in a pharmacokinetic study in 12 healthy males administered 2 mg/kg (2R,4R)-monatin.
A thorough QTc study was conducted and showed QT prolongation of 25 ms after a single dose of 150 mg (2R,4R)-monatin.
QTc prolongation at high (2R,4R)-monatin plasma levels is a significant finding.